Skip to main content
Behavioral Healthcare Executive
Abuse, PTSD & Trauma
Alzheimer’s Disease, Dementia & Cognitive Disorders
Child & Adolescent Psychiatry
Coping During COVID-19
Expert Insights in Advanced Psychopharmacology
Major Depressive Disorder
Your Questions Answered
CME Conference Calendar
Cocaine, Meth & Stimulant Summit
Evolution of Psychotherapy
National Conference on Addiction Disorders East
National Conference on Addiction Disorders West
Psych Congress Elevate
Psych Congress Regionals
Rx Drug Abuse & Heroin Summit
Treatment Center Investment & Valuation Retreat
APA Key Clinical Topics
Psych Congress On-Demand
NCAD East On-Demand
Centers of Excellence
Advertising And Event Opportunities
Editorial Advisory Board
Classifieds & Jobs for Healthcare Professionals
Limiting the Misuse and Diversion of Prescription Stimulants
November 03, 2020
In this video, Timothy Wilens, MD, of Harvard Medical School, discusses strategies for limiting the misuse and diversion of prescription stimulants.
YOUR QUESTIONS ANSWERED
Dr. Rakesh Jain on Using LAIs in Patients With Dementia and Delusions
November 02, 2020
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the use of long-acting injectables for patients with dementia and paranoia or other delusions.
Dr. Marc Agronin on Prescribing Psychotropic Medications for Older Adults
October 28, 2020
In this video, geriatric psychiatrist Marc E. Agronin, MD, shares guidelines for appropriately prescribing psychotropic medications for older adults.
The Role of Stimulants in ADHD Treatment
October 26, 2020
In this video, psychiatrist Birgit Amann, MD, discusses the common myth that stimulants are a good treatment option for all patients with attention-deficit/hyperactivity disorder (ADHD).
What Does Imaging Data Show Us About Schizophrenia?
October 22, 2020
In this video from Psych Congress 2020, Sanjai Rao, MD, discusses whether imaging data could play a role in diagnosing schizophrenia.
Emerging Treatment Approaches for ADHD
October 22, 2020
Psych Congress 2020 cochair Vladimir Maletic, MD, MS, discusses emerging treatments and mechanisms of action for attention deficit/hyperactivity disorder (ADHD).
Evaluating the Long-term Efficacy and Safety of Deutetrabenazine
October 21, 2020
In this video, Joohi Jimenez‑Shahed, MD, explains a 3-year, open-label study which evaluated the long-term efficacy and safety of deutetrabenazine, a treatment for the movement disorder tardive…
Guidelines for Using Lithium as a Treatment for Bipolar Disorder
October 20, 2020
In this video, Joseph F. Goldberg, MD, explains the conditions under which lithium may be an effective treatment for patients with bipolar disorder.
Can Genomic Data Aid in the Diagnosis of Schizophrenia?
October 20, 2020
In this video, Sanjai Rao, MD, of the University of California San Diego School of Medicine, discusses whether genomic data can aid in the diagnosis of schizophrenia.
Anxiety and Mood Disorders in Children and Adolescents With ADHD
October 19, 2020
Neurodevelopmental pediatrician Frank Lopez, MD, addresses the myth that anxiety and mood disorders do not co-occur with attention-deficit/hyperactivity disorder (ADHD).
Efforts to Promote Diversity, Equity and Inclusion Highlight NACBHDD Meeting
Rethinking Thanksgiving: Five Tips for Finding Joy and Hope in the Midst of Change
Pandemic Calls for Population Behavioral Health Strategy
Prescription Digital Therapeutics: How reSET® and reSET-O® are Bridging Gaps in the Treatment of SUD and OUD
Create Real Value Through Your Marketing
All Aboard! How To Build Better Staff Buy-In For A New EHR
Medication Adherence Rating Scale (MARS)
Sheehan Disability Scale (SDS)
Brief Psychiatric Rating Scale (BPRS)
Stay in the know.
Psychiatry and Behavioral Health Learning Network Newsletter
Back to Top